Pharmafile Logo

Glaucoma in perspective

- PMLiVE

Celgene scoops Socially Responsible Initiative prize at PMEA 2016

Lauded for 'inspirational' initiative that tackled real need in developing countries

- PMLiVE

How digital content helps HCPs curb opioid abuse through better prescribing decisions

The patient experience and possibly adherence is affected by the extent to which they feel their participation is valued

UK pharma continues to approach social media cautiously

Novartis UK becomes the latest in a trickle of firms to join Twitter

- PMLiVE

Janssen files Stelara follow-up guselkumab in Europe

Trial data shows J&J’s drug is more effective in treating psoriasis than AbbVie’s Humira

- PMLiVE

GSK set for 2017 European rollout of med device asthma app

Updated version of the MyAsthma iPhone app is firm's first Class 1 med device

Actelion HQ Switzerland

Resurgent Actelion catches J&J’s eye

Confirms talks of possible take over after Uptravi sees ‘outstanding’ sales

- PMLiVE

Branding Science adds to senior management team

Jon Chandler joins the market research consultancy

- PMLiVE

Real-world evidence

Investigating the sources of evidence as best practice moves from being knowledge-based to evidence-based

- PMLiVE

Takeda gets EU green light for oral myeloma drug

Ninlaro first oral proteasome inhibitor to be registered in Europe

- PMLiVE

GSK starts late-stage trials of daprodustat

Drug hopes to treat anaemia caused by chronic kidney disease

- PMLiVE

Healthcare and the artificial intelligence revolution

How technologists and healthcare professionals are working together to improve patient outcomes

- PMLiVE

Dr Irina Antonijevic joins vasopharm

Becomes chief medical officer of the cerebrovascular specialist

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links